We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CMLFU market cap is 336.49M. The company's latest EPS is USD -6.7906 and P/E is -1.64.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 83.23M | 61.35M | 43.14M | 49.04M | 53.3M |
| Operating Income | -93.83M | -114.74M | -58.24M | -51.62M | -34.35M |
| Net Income | -77.58M | -308.76M | -60.99M | -46.72M | -43.32M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 212.2M | 234.69M | 202.57M |
| Operating Income | -206k | -446.15M | -457.51M | -182.3M |
| Net Income | -192k | -245.39M | -548.98M | -175.77M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 828.97M | 490.94M | 545.3M | 476.39M | 417.29M |
| Total Liabilities | 267.68M | 237.24M | 216.83M | 180.28M | 163.03M |
| Total Equity | 561.29M | 253.71M | 328.47M | 296.11M | 254.26M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 444.14M | 554.09M | 490.94M | 418.76M |
| Total Liabilities | 15.59M | 165.99M | 237.24M | 190.74M |
| Total Equity | 5M | 388.1M | 253.71M | 228.02M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -254.5M | -319.16M | -55.56M | -109.06M | -150.29M |
| Investing | -138.49M | -141.33M | -462k | -11.73M | -38.86M |
| Financing | 197.25M | 197.32M | 132.66M | 140.05M | 139.14M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -386k | -190.43M | -319.16M | -180.15M |
| Investing | -442.75M | -20.79M | -141.33M | -43.73M |
| Financing | 444.23M | 493.73M | 197.32M | 186.24M |
| Market Cap | 336.49M |
| Price to Earnings Ratio | -1.64 |
| Price to Sales Ratio | 1.43 |
| Price to Cash Ratio | 2.9 |
| Price to Book Ratio | 1.27 |
| Dividend Yield | - |
| Shares Outstanding | 25.88M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 12.45 (92.57%) |
| Company Name | CM Life Sciences Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.genedx.com |
| Industry | health services (8000) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
